Relevant conflicts of interest/financial disclosures: Nothing to report.
Letters: New Observations
Leukodystrophies in idiopathic adult-onset ataxia: Frequency and phenotype in 105 patients
Article first published online: 7 AUG 2013
© 2013 Movement Disorder Society
How to Cite
Müller vom Hagen, J., Synofzik, M., Schicks, J., Krägeloh-Mann, I. and Schöls, L. (2013), Leukodystrophies in idiopathic adult-onset ataxia: Frequency and phenotype in 105 patients. Mov. Disord.. doi: 10.1002/mds.25617
Full financial disclosures and author roles may be found in the online version of this article.
Dr. J. Müller vom Hagen received a travel grant by Actelion Pharmaceuticals.
Dr. Synofzik received a research grant by the Volkswagen Foundation, a travel grant by the Movement Disorders Society, and honoria from Fresenius Kabi and Actelion Pharmaceuticals.
Dr. Schicks received a travel grant by the Movement Disorder Society and a research grant by the fortune-Programm, University of Tuebingen (1890-0-0).
Dr. Schöls received research grants of the Deutsche Forschungsgemeinschaft (SCHO754/4-1 and SCHO754/5-1), grants of the German Research Council (BMBF) to Leukonet (01GM0644) and mitoNET (01GM0864) and E-RARE grants to EUROSPA (01GM0807) and RISCA (01GM0820). He further received funding from the HSP-Selbsthilfegruppe Deutschland eV.
Dr. Krägeloh-Mann was member of the scientific board of the biopharmaceutical company ZYMENEX for a clinical trial I/II-study for enzyme replacement in MLD in 2007; and is currently member of the scientific board of the biopharmaceutical company SHIRE for a world-wide clinical trial I/II-study for intrathecal enzyme replacement in MLD. This did not imply any involvement, nor funding in the present study.
- Article first published online: 7 AUG 2013
- Manuscript Accepted: 14 JUN 2013
- Manuscript Revised: 26 APR 2013
- Manuscript Received: 25 AUG 2012